Shandong Sanyuan Biotechnology Co.,Ltd.
SZSE:301206.SZ
27.83 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 108.808 | 489.042 | 515.72 | 224.975 | 143.561 | 64.291 | 47.154 | 50.638 | 8.97 | 0.202 | 2.562 |
| Short Term Investments
| 0 | 0 | 0.327 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 |
| Cash and Short Term Investments
| 108.808 | 489.042 | 516.047 | 224.975 | 143.561 | 64.291 | 47.154 | 50.638 | 8.97 | 0.202 | 2.662 |
| Net Receivables
| 97.544 | 60.394 | 171.344 | 79.975 | 49.343 | 40.261 | 28.244 | 5.801 | 3.998 | 15.821 | 14.708 |
| Inventory
| 104.331 | 96.774 | 112.157 | 68.206 | 45.904 | 19.836 | 8.572 | 11.386 | 8.877 | 10.936 | 9.849 |
| Other Current Assets
| 11.13 | 23.158 | 6.077 | 5.51 | 0.166 | 3.724 | 0.77 | 3.721 | 1.307 | 0.017 | 0.407 |
| Total Current Assets
| 321.814 | 669.368 | 805.624 | 378.665 | 238.974 | 128.111 | 84.739 | 71.547 | 23.151 | 26.976 | 27.625 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 996.061 | 952.982 | 770.606 | 364.306 | 246.912 | 134.257 | 78.228 | 32.991 | 21.852 | 14.681 | 15.278 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 47.577 | 48.728 | 49.135 | 30.148 | 30.843 | 15.943 | 16.322 | 16.872 | 17.16 | 14.546 | 0.907 |
| Goodwill and Intangible Assets
| 47.577 | 48.728 | 49.135 | 30.148 | 30.843 | 15.943 | 16.322 | 16.872 | 17.16 | 14.546 | 0.907 |
| Long Term Investments
| 58.898 | 60.156 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0.9 |
| Tax Assets
| 0 | -60.156 | 2.518 | 2.414 | 2.33 | 0.017 | 0.001 | 0 | 0 | -1 | 0.1 |
| Other Non-Current Assets
| 3,386.077 | 3,198.841 | 6.274 | 5.857 | 4.684 | 1.304 | 1.827 | 5.668 | 3.782 | 1.07 | 0.368 |
| Total Non-Current Assets
| 4,488.613 | 4,200.552 | 828.533 | 402.725 | 284.768 | 151.521 | 96.378 | 55.531 | 43.795 | 30.296 | 17.553 |
| Total Assets
| 4,810.426 | 4,869.919 | 1,634.157 | 781.391 | 523.742 | 279.632 | 181.118 | 127.078 | 66.945 | 57.272 | 45.178 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 46.24 | 184.314 | 542.469 | 238.848 | 158.217 | 77.523 | 49.725 | 37.005 | 17.406 | 11.147 | 1.385 |
| Short Term Debt
| 164.548 | 102.117 | 436.733 | 200.477 | 116.597 | 53.166 | 0 | 0 | 6 | 0 | 4.5 |
| Tax Payables
| 1.123 | 2.151 | 3.887 | 4.835 | 4.81 | 8.391 | 0.605 | 0 | 0 | 0.213 | 0.14 |
| Deferred Revenue
| 5.178 | 4.218 | 11.427 | 11.106 | 1.288 | 2.194 | 0 | 0 | 0 | 0 | 11.802 |
| Other Current Liabilities
| 8.231 | -83.138 | -425.816 | -191.541 | -106.644 | -33.851 | 14.635 | 3.431 | 1.236 | 18.249 | 0.021 |
| Total Current Liabilities
| 224.197 | 207.511 | 564.814 | 258.89 | 169.458 | 99.032 | 64.36 | 40.436 | 24.643 | 29.396 | 17.708 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 4.593 | 0.855 | 0.989 | 1.223 | 0.953 | 1.084 | 0.951 | 0 | 0 | 1.281 | 1.391 |
| Deferred Tax Liabilities Non-Current
| 43.614 | 40.777 | 23.026 | 11.364 | 5.176 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| -4.593 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 43.614 | 41.632 | 24.015 | 12.587 | 6.129 | 1.084 | 0.951 | 0 | 0 | 1.281 | 1.391 |
| Total Liabilities
| 267.811 | 249.143 | 588.829 | 271.477 | 175.587 | 100.116 | 65.311 | 40.436 | 24.643 | 30.677 | 19.099 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 202.326 | 202.326 | 101.163 | 101.163 | 101.163 | 48.668 | 48.668 | 37.428 | 30 | 20 | 20 |
| Retained Earnings
| 745.063 | 833.754 | 821.452 | 289.64 | 151.139 | 81.997 | 25.584 | 20.946 | 2.495 | 0.458 | -0.058 |
| Accumulated Other Comprehensive Income/Loss
| 74.532 | 68.595 | 52.094 | 119.111 | 95.853 | 48.852 | -0 | 0 | 0 | -0 | 0 |
| Other Total Stockholders Equity
| 3,516.102 | 3,516.102 | 70.62 | 0 | 0 | 0 | 41.555 | 27.208 | 8.638 | 6.138 | 6.138 |
| Total Shareholders Equity
| 4,538.023 | 4,620.776 | 1,045.329 | 509.914 | 348.155 | 179.516 | 115.807 | 85.581 | 41.132 | 26.595 | 26.079 |
| Total Equity
| 4,538.023 | 4,620.776 | 1,045.329 | 509.914 | 348.155 | 179.516 | 115.807 | 85.581 | 41.132 | 26.595 | 26.079 |
| Total Liabilities & Shareholders Equity
| 4,810.426 | 4,869.919 | 1,634.157 | 781.391 | 523.742 | 279.632 | 181.118 | 126.017 | 65.775 | 57.272 | 45.178 |